Nicotinamide Attenuates the Decrease of Astrocytic Phosphoprotein PEA-15 in Focal Cerebral Ischemic Injury

DOI DOI Web Site Web Site Web Site View 3 Remaining Hide 29 References
  • KOH Phil-Ok
    Department of Anatomy, College of Veterinary Medicine, Research Institute of Life Science, Gyeongsang National University

Bibliographic Information

Other Title
  • Nicotinamide Restores the Reduction of Parvalbumin in Cerebral Ischemic Injury

Search this article

Abstract

Nicotinamide exerts neuroprotective effects against focal cerebral ischemic injury. Phosphoprotein enriched in astrocytes 15 (PEA-15) is prominently expressed in astrocytes that exert broad anti-apoptotic functions. This study investigated whether nicotinamide modulates PEA-15 and levels of two phosphorylated PEA-15 (Serine 104 and 116) in an animal model of middle cerebral artery occlusion (MCAO)-induced injury. Adult male rats were treated with vehicle or nicotinamide (500 mg/kg) 2 hr after the onset of MCAO and cerebral cortices were collected at 24 hr after MCAO. In a proteomic approach, MCAO induced decreases of PEA-15 levels, while nicotinamide treatment attenuated the injury-induced decrease in PEA-15. The results of Western blot analysis suggest that nicotinamide prevented injury-induced reduction in phospho-PEA-15 (Serine 104) and phospho-PEA-15 (Serine 116) levels. The phosphorylation of PEA-15 exerts anti-apoptotic functions, and reduction of PEA-15 phosphorylation leads to apoptotic cell death. These results suggest that nicotinamide exerts a neuroprotective effect by attenuating the injury-induced decreases of PEA-15 and phospho-PEA-15 (Ser 104 and Ser 116) proteins.<br>

Journal

References(29)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top